| magic story very thanks http://www.whitneymartindesign.com/best-essay-writing-reviews/ rogerian essay topics Finally, testing will not become more available if the court rules against Myriad because the patent claims at issue are not infringed by BRCA genetic testing. Myriad's patents related to BRCA will expire over the next few years. For those who understand how such testing actually gets done, the likelihood is overwhelming that testing costs will not go down and patient access due to competition will not go up as much as the opposing side would have you believe.
|